Ibrahim Elghissassi
Allal Elfassi Street
Rabat, Morocco
Rabat, Morocco
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Post-neoadjuvant and peri-operative ctDNA-defined minimal residual disease in triple-negative breast cancer: a systematic review and meta-analysis.
Journal: Breast cancer research and treatment
Published: February 18, 2026
Spatial and temporal intratumoral heterogeneity in breast cancer: a systematic and conceptual review of single-cell and spatial omics studies.
Journal: BMC cancer
Published: August 27, 2025
Knowledge and views of physicians and nurses about physical activity advice in oncology care: a cross-sectional study.
Journal: The Pan African medical journal
Published: June 01, 2021
Frequency and types of EGFR mutations in Moroccan patients with non-small cell lung cancer.
Journal: Tumori
Published: October 20, 2020
The Frequency and Specific Features of Rare Epidermal Growth Factor Receptor Mutations in Moroccan Patients with Lung Adenocarcinoma whose Tumors harbor positive EGFR mutations.
Journal: The Gulf journal of oncology
Published: February 18, 2020
Frequency of anaplastic lymphoma kinase rearrangements in Moroccan patients with non small cell lung cancer: a multi-institutional national retrospective study.
Journal: BMC cancer
Published: August 06, 2019
Lung Cancer in the Middle East and North Africa Region.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 15, 2019
Breast Adenoid Cystic Carcinoma: A Rare Case Report and Review of the Literature.
Journal: The Gulf journal of oncology
Published: April 01, 2017
Breast metastasis from recurrent gallbladder adenocarcinoma: a case report with review of the literature.
Journal: Journal of gastrointestinal oncology
Published: August 12, 2016
Which Epidemiological Factors Have the Most Influence on the EGFR Mutation Frequency in Lung Adenocarcinoma?
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 16, 2016
Second-line treatment of non-small-cell lung cancer with wild-type EGFR status. What is the best approach?
Journal: Current oncology (Toronto, Ont.)
Published: April 29, 2016
Last Updated: 09/26/2026